Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Yiviva Presents Phase 2b Results for YIV-906 in Combination with Sorafenib in Advanced Hepatocellular Carcinoma at ASCO and ESMO GI 2025
-
Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States
-
Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro™ (repotrectinib)
-
Kvika banki hf.: Transaction in relation to a share buy-back programme
-
At the Yacht Club de Monaco nautical prototypes and laboratories come together for the zero emissions goal
-
WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE S&P 500 3X DAILY SHORT SECURITIES ISIN: IE00B8K7KM88
-
OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin
-
OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin
-
IREN June 2025 Monthly Update
-
Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Adv
-
The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region
-
New Business Book Unveils 17 Proven Rules to Save, Sustain, and Scale Struggling Companies
-
Lightchain AI Opens Bonus Round Following $20.9M Raised Across 15 Presale Stages
-
BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
-
CORRECTION – Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets
-
Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
-
Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema
-
Aya Gold & Silver Reports High-Grade Boumadine Exploration Results, Expands Imariren to 1km and Identifies New High-Grade Asirem Zone to the West
-
Lancaster Strengthens Gold Portfolio with Completion of Lake Cargelligo Acquisition
-
Carlton Announces Results of Annual and Special Meeting of Shareholders
-
Western Financial Group Wins 2025 Canadian Business Excellence Award
-
VitalHub Announces Acquisition of Novari Health Inc.
-
BeyondSpring Publishes Human Clinical Study in Med (Cell Press) Showing Plinabulin-Driven Dendritic Cell Maturation and Tumor Response After Prior Checkpoint Inhibitor Failure
-
Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21
-
Inventus Reports 4.10 gpt Gold and 1.78 Metre Average in 30 Drill Holes Within 6 Metres of Surface at the 10,000-Tonne Trench 1 Bulk Sample Site
-
La Caisse and Fondaction invest $250 million by way of a subordinated loan to Boralex
-
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
-
Tonix Pharmaceuticals Announces Oral Presentation on Mpox and Smallpox vaccine candidate TNX-801 at the Vaccine Congress 2025
-
Unicycive Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference
-
Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia
-
European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia
-
Heidmar Maritime Holdings Corp. Acquires Its First Vessel and Establishes Foothold in Container Shipping
-
Denodo Announces Plans to Further Support AI Innovation by Releasing Denodo DeepQuery, a Deep Research Capability
-
Talisker Initiates Milling at Nicola’s Craigmont Mill
-
Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21
-
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
-
Inventus Reports 4.10 gpt Gold and 1.78 Metre Average in 30 Drill Holes Within 6 Metres of Surface at the 10,000-Tonne Trench 1 Bulk Sample Site
-
Shoals Technologies Group, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call
-
OTC Markets Group Welcomes Vroom, Inc. to OTCQX
-
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
-
Signify share repurchase period update
-
OMass Therapeutics to Present New Preclinical Data For its Best-in-Class MC2 Program at ENDO 2025
-
MAG Silver Reminds Shareholders to Vote “FOR” the Arrangement with Pan American Silver
-
CGTN: How is Greater BRICS empowering the Global South?
-
Dundee Precious Metals Announces Receipt of Environmental Licence for the Loma Larga Project and Provides Update on the Feasibility Study Results Timing
-
Blue Moon Metals Selects Worley to Prepare a NI 43-101 Feasibility Study For the Nussir Project in Q1-2026 and Advance Basic Engineering
-
Blue Moon Metals Selects Worley to Prepare a NI 43-101 Feasibility Study For the Nussir Project in Q1-2026 and Advance Basic Engineering
-
Descartes MacroPoint™ FraudGuard 2.0 Provides Transportation Industry with Next-Generation Solution for Freight Fraud Defense
-
Bitcoin Solaris Announces LBank Listing and 72-Hour Price Rollback to $5
-
At the Yacht Club de Monaco, a discussion on alternative fuels for the future of the maritime sector
